Clinical Trials Browser

INDUSTRY × Interventional × rubitecan × Clear all

NCT00113113 2024-08-02

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Phase 1 Completed

Liver Diseases, Neoplasms, Renal Insufficiency

NCT00113256 2024-08-02

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Phase 2/3 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms